Preventive effect of renin-angiotensin system inhibitor on left atrial remodelling in patients with chronic atrial fibrillation: Long-term echocardiographic study

European Journal of Echocardiography

Volumn 12, Issue 4, 2011, Pages 278-282

  Fukuda, Yamato ^a   Fukuda, Nobuo ^a   Morishita, Satofumi ^a   Tamura, Yoshiyuki ^a  

^a National Hospital Organization Zentsuji Hospital   (Japan)

Author keywords

Atrial fibrillation; Left atrial remodelling; RAS inhibitor

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART ATRIUM ENLARGEMENT; HEART ATRIUM FIBRILLATION; HEART LEFT ATRIUM REMODELLING; HUMAN; MALE; PRIORITY JOURNAL; TREATMENT RESPONSE;

AGED; ANGIOTENSIN RECEPTOR ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ATRIAL FIBRILLATION; CHRONIC DISEASE; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART ATRIA; HUMANS; LINEAR MODELS; LONGITUDINAL STUDIES; MALE; RENIN-ANGIOTENSIN SYSTEM; TREATMENT OUTCOME;

EID: 79953884636     PISSN: 15252167     EISSN: 15322114     Source Type: Journal    
DOI: 10.1093/ejechocard/jeq193     Document Type: Article

References (30)

1. Kannel WB, Abbott RD, Savage DD, McNamara PM. Epidemiologic features of chronic atrial fibrillation: the Framingham study. N Engl J Med 1982;306:1018-22. (Pubitemid 12155370)
2. Murgatroyd FD, Camm AJ. Atrial arrhythmias. Lancet 1993;341:1317-22. (Pubitemid 23148101)
3. Petersen P, Kastrup J, Brinch K, Godtfredsen J, Boysen G. Relation between left atrial dimension and duration of atrial fibrillation. Am J Cardiol 1987;60:382-4. (Pubitemid 17133072)
4. Petersen P. Thromboembolic complications in atrial fibrillation. Stroke 1990; 21:4-13. (Pubitemid 20052524)
5. Naito S, Imataka K, Seko Y, Fujii J. The predictive factors for cerebral infarction in patients with non-rheumatic atrial fibrillation.J Cardiol 1990;20:385-91.
6. Moss AJ. Atrial fibrillation and cerebral embolism. Arch Neurol 1984;41:707. (Pubitemid 14124621)
7. Caplan LR, D'Cruz I, Hier DB, Reddy H, Shah S. Atrial size, atrial fibrillation, and stroke. Ann Neurol 1986;19:158-61. (Pubitemid 16114169)
8. Tsang TS, Barnes ME, Gersh BJ, Bailey KR, Seward JB. Left atrial volume as a mor-phophysiologic expression of left ventricular diastolic dysfunction and relation to cardiovascular risk burden. Am J Cardiol 2002;90:1284-9. (Pubitemid 35449471)
9. Pritchett AM, Mahoney DW,Jacobsen SJ, Rodeheffer RJ, Karon BL, Redfield MM. Diastolic dysfunction and left atrial volume: a population-based study. J Am Coll Cardiol 2005;45:87-92. (Pubitemid 40052032)
10. Thijssen VL, Ausma J, Borgers M. Structural remodelling during chronic atrial fibrillation: act of programmed cell survival. Cardiovasc Res 2001;52:14-24. (Pubitemid 32835235)
11. Allessie M, Ausma J, Schotten U. Electrical, contractile and structural remodeling during atrial fibrillation. Cardiovasc Res 2002;54:230-46. (Pubitemid 34327903)
12. Hirayama Y, Atarashi H, Kobayashi Y, Horie T, Iwasaki Y, Maruyama M et al. Angiotensin-converting enzyme inhibitor therapy inhibits the progression from paroxysmal atrial fibrillation to chronic atrial fibrillation. Circ J 2005;69:671-6. (Pubitemid 40812368)
13. Schiller NB, Acquatella H, Ports TA, Drew D, Goerke J, Ringertz H et al. Left ventricular volume from paired biplane two-dimensional echocardiography. Circulation 1979;60:547-55. (Pubitemid 9254058)
14. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I et al. Echo-cardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986;57:450-8. (Pubitemid 16119719)
15. Oh JK, Appleton CP, Hatle LK, Nishimura RA, Seward JB, Tajik AJ. The noninva-sive assessment of left ventricular diastolic function with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 1997;10:246-70. (Pubitemid 127789858)
16. Ausma J, Wijffels M, Thoné F, Wouters L, Allessie M, Borgers M. Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat Circulation 1997;96:3157-63. (Pubitemid 27500121)
17. Everett TH, Li H, Mangrum JM, McRury ID, Mitchell MA, Redick JA et al. Electrical, morphological, and ultrastructural remodeling and reverse remodeling in a canine model of chronic atrial fibrillation. Circulation 2000;102:1454-60.
18. Mattioli AV, Sansoni S, Lucchi GR, Mattioli G. Serial evaluation of left atrial dimen-sion after cardioversion for atrial fibrillation and relation to atrial function. Am J Cardiol 2000;85:832-6. (Pubitemid 30157848)
19. Ommen SR, Nishimura RA, Appleton CP, Miller FA, Oh JK, Redfield MM et al. Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: a comparative simultaneous Doppler-catheterization study. Circulation 2000;102:1788-94.
20. Van Den Berg MP, Crijns HJ, Van Veldhuisen DJ, Griep N, De Kam PJ, Lie KI. Effects of lisinopril in patients with heart failure and chronic atrial fibrillation. J Card Fail 1995;1:355-63.
21. Pedersen OD, Bagger H, Kober L, Torp-Pedersen C Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction. Circulation 1999;100:376-80. (Pubitemid 29362407)
22. Goette A, Staack T, Röcken C, Arndt M, Geller JC, Huth C et al. Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation.JAm Coll Cardiol 2000;35:1669-77. (Pubitemid 30307515)
23. Kumagai K, Nakashima H, Urata H, Gondo N, Arakawa K, Saku K. Effects of angio-tensin II type 1 receptor antagonist on electrical and structural remodeling in atrial fibrillation.J Am Coll Cardiol 2003;41:2197-204. (Pubitemid 36724267)
24. Oki T, Tabata T, Yamada H, Wakatsuki T, Shinohara H, Nishikado A et al. Clinical application of pulsed Doppler tissue imaging for assessing abnormal left ventricu-lar relaxation. Am J Cardiol 1997;79:921-8. (Pubitemid 27197927)
25. Ihara M, Urata H, Shirai K, Ideishi M, Hoshino F, Suzumiya J et al. High cardiac angiotensin-II-forming activity in infarcted and non-infarcted human myocardium. Cardiology 2000;94:247-53. (Pubitemid 32402287)
26. Shiroshita-Takeshita A, Brundel BJ, Burstein B, Leung TK, Mitamura H, Ogawa S et al. Effects of simvastatin on the development of the atrial fibrillation substrate in dogs with congestive heart failure. Cardiovasc Res 2007;74:75-84. (Pubitemid 46366949)
27. Shiroshita-Takeshita A, Schram G, Lavoie J, Nattel S. Effect of simvastatin and anti-oxidant vitamins on atrial fibrillation promotion by atrial-tachycardia remodeling in dogs. Circulation 2004;110:2313-9. (Pubitemid 39407332)
28. Kumagai K, Nakashima H, Saku K The HMG-CoA reductase inhibitor atorvastatin prevents atrial fibrillation by inhibiting inflammation in a canine sterile pericarditis model. Cardiovasc Res 2004;62:105-11. (Pubitemid 38326816)
29. Hanna IR, Heeke B, Bush H, Brosius L, King-Hageman D, Dudley SC Jr. et al. Lipid-lowering drug use is associated with reduced prevalence of atrial fibrillation in patients with left ventricular systolic dysfunction. Heart Rhythm 2006;3:881-6. (Pubitemid 44103516)
30. Carnes CA, Chung MK, Nakayama T, Nakayama H, Baliga RS, Piao S et al. Ascor-bate attenuates atrial pacing-induced peroxynitrite formation and electrical remo-deling and decreases the incidence of postoperative atrial fibrillation. Circ Res 2001;89:E32-8.